ASSET PURCHASE AGREEMENT BY AND AMONG JANSSEN BIOTECH, INC. AND ORBIT BIOMEDICAL LIMITED dated as of March 29, 2018Asset Purchase Agreement • April 16th, 2021 • Gyroscope Therapeutics Holdings LTD • Biological products, (no disgnostic substances) • New York
Contract Type FiledApril 16th, 2021 Company Industry JurisdictionThis Asset Purchase Agreement (this “Agreement”), dated as of March 29, 2018, is entered into by and between Janssen Biotech, Inc., a Pennsylvania corporation (“Seller”), Orbit Biomedical Limited, a limited company organized under the Laws of England and Wales (“Buyer”). Seller and Buyer are sometimes individually referred to herein as a “Party” and are sometimes collectively referred to herein as the “Parties.”
ASSET PURCHASE AGREEMENT BY AND AMONG JANSSEN BIOTECH, INC. AND ORBIT BIOMEDICAL LIMITED dated as of March 29, 2018Asset Purchase Agreement • January 11th, 2021 • Gyroscope Therapeutics Holdings LTD • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 11th, 2021 Company Industry JurisdictionThis Asset Purchase Agreement (this “Agreement”), dated as of March 29, 2018, is entered into by and between Janssen Biotech, Inc., a Pennsylvania corporation (“Seller”), Orbit Biomedical Limited, a limited company organized under the Laws of England and Wales (“Buyer”). Seller and Buyer are sometimes individually referred to herein as a “Party” and are sometimes collectively referred to herein as the “Parties.”